Anticoagulant activity in human plasma assessed as prolongation of activated partial thromboplastin time by measuring concentration required to double APTT incubated for 3 mins by coagulometer analysis
Anticoagulant activity in human plasma assessed as prolongation of prothrombin time by measuring concentration required to double PT incubated for 3 mins by coagulometer analysis
Anticoagulant activity in human plasma assessed as prolongation of thrombin time by measuring concentration required to double TT incubated for 3 mins by coagulometer analysis
Inhibition of coagulation factor Xa (unknown origin) using chromogenic substrate incubated for 7 min in presence of antithrombin by absorbance based assay
Anticoagulant activity in human platelet poor plasma assessed as inhibition of thrombin generation incubated for 3 mins by calibrated automated thrombogram analysis
Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 100 nmol/kg, sc measured after 1 hr relative to control
Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 30 nmol/kg, sc measured after 2 hrs relative to control
Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 100 nmol/kg, sc measured after 2 hrs relative to control
Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 300 nmol/kg, sc measured after 2 hrs relative to control